category,datetime,headline,id,image,related,source,summary,url
company,1768425000,Is Regeneron (REGN) Offering Value After Recent Share Price Swings?,138115660,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,REGN,Yahoo,"If you are wondering whether Regeneron Pharmaceuticals at around US$758.91 represents fair value or a potential opportunity right now, you are not alone. The stock has had mixed recent returns, with a 2.3% decline over the last 7 days, a 2.4% gain over the last 30 days, a 2.2% decline year to date, and a 10.5% return over the past year, alongside 4.8% and 42.9% returns over the last 3 and 5 years. Recent attention on Regeneron has centered on its position in the pharmaceuticals and biotech...",https://finnhub.io/api/news?id=8a003ec085f5482ec812d480628a89b2bc47af751f7be3c3ad3f84ebdc82f5af
company,1768417556,JPM26: Regeneron will not overpay in M&A deals amid lead asset patent expiries,138114828,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,REGN,Yahoo,"The company will prioritise investment for in-house innovation over large M&A deals, bucking the trend across pharma.",https://finnhub.io/api/news?id=0222852a318b73255d22e3c6239c346281539f73dd30a652b065167793d1eec2
